Home/Filings/4/0000874015-24-000020
4//SEC Filing

Cadoret-Manier Onaiza 4

Accession 0000874015-24-000020

CIK 0000874015other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:23 PM ET

Size

5.8 KB

Accession

0000874015-24-000020

Insider Transaction Report

Form 4
Period: 2024-01-02
Cadoret-Manier Onaiza
Chief Corp Development Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2024-01-02+43,20043,200 total
    Exercise: $52.87From: 2025-01-02Exp: 2034-01-01Common Stock (43,200 underlying)
Footnotes (1)
  • [F1]Grant on 01/02/2024 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2024. 25% of the shares subject to the option will vest and become exercisable on 01/02/2025. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

Related Parties

1
  • filerCIK 0001799355

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:23 PM ET
Size
5.8 KB